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of an aggressive clinical presentation. Recently, it has been proposed that the clinical presentation should
be considered as an additional independent factor determining the clinical course of these lesions. How-
ever, dural shunts with leptomeningeal venous drainage include a very wide spectrum of inhomogeneous
lesions. In the current study, we correlated the clinical presentation of 107 consecutive patients harboring
cranial dural arteriovenous shunts with leptomeningeal venous drainage, with their distinct anatomic and
angiographic features categorized into eight groups based on the “DES” (Directness and Exclusivity of
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groups, there are significant angioarchitectural differences, which are reflected by considerable differences
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exclusive and without venous strain manifested only benign symptoms (aggressive presentation 0 %). On
the other end of the spectrum, the bridging vein shunts with direct and exclusive leptomeningeal venous
drainage and venous strain are expected to present aggressive symptoms almost always and most likely
with bleeding (aggressive presentation 91.5 %). Important aspects of the above correlations are discussed.
Therefore, the consideration of leptomeningeal venous drainage alone, for prediction of the clinical pre-
sentation of these shunts appears insufficient. Angiographic analysis based on the above concept, offers
the possibility to distinguish the higher- from the lower-risk types of leptomeningeal venous drainage.
In this context, consideration of the clinical presentation as an additional independent factor for the
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to the clinical presentation of the dural shunts inasmuch as the former determines the venous anatomy
and the angioarchitectural features of the lesions.
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Abstract Cranial dural arteriovenous fistulae have been clas-
sified into high- and low-risk lesions mainly based on the
pattern of venous drainage. Those with leptomeningeal ve-
nous drainage carry a higher risk of an aggressive clinical
presentation. Recently, it has been proposed that the clinical
presentation should be considered as an additional indepen-
dent factor determining the clinical course of these lesions.
However, dural shunts with leptomeningeal venous drainage
include a very wide spectrum of inhomogeneous lesions. In
the current study, we correlated the clinical presentation of
107 consecutive patients harboring cranial dural arteriovenous
shunts with leptomeningeal venous drainage, with their dis-
tinct anatomic and angiographic features categorized into
eight groups based on the “DES” (Directness and Exclusivity
of leptomeningeal venous drainage and features of venous
Strain) concept. We found that among these groups, there
are significant angioarchitectural differences, which are
reflected by considerable differences in clinical presentation.
Leptomeningeal venous drainage of dural sinus shunts that is
neither direct nor exclusive and without venous strain mani-
fested only benign symptoms (aggressive presentation 0 %).
On the other end of the spectrum, the bridging vein shunts
with direct and exclusive leptomeningeal venous drainage and
venous strain are expected to present aggressive symptoms
almost always and most likely with bleeding (aggressive
presentation 91.5 %). Important aspects of the above correla-
tions are discussed. Therefore, the consideration of
leptomeningeal venous drainage alone, for prediction of the
clinical presentation of these shunts appears insufficient. An-
giographic analysis based on the above concept, offers the
possibility to distinguish the higher- from the lower-risk types
of leptomeningeal venous drainage. In this context, consider-
ation of the clinical presentation as an additional independent
factor for the prediction of their clinical course seems super-
fluous and possibly misleading. Topography is connected to
the clinical presentation of the dural shunts inasmuch as the
former determines the venous anatomy and the
angioarchitectural features of the lesions.
Keywords Dural arteriovenous shunt . Dural arteriovenous
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Introduction
Cranial dural arteriovenous fistulae (CDAVF) with
leptomeningeal venous drainage (LVD) are complex vascular
lesions, which carry a significant risk of an aggressive clinical
presentation and have a poor natural history [11, 4, 25, 24, 6,
26, 1]. Recent reports have proposed that lesions with a benign
presentation have a better clinical course in comparison to
those with an aggressive clinical presentation [4, 11, 25, 24].
However, lesions with LVD constitute a very heterogeneous
group since they inc lude shunts wi th di fferent
angioarchitectural features. Analyses, which do not take into
consideration the spectrum of these features and the corre-
sponding subgroups of lesions with LVD, may lead to erro-
neous conclusions. Assuming that presentationmay be closely
related to the above features, being presumably their clinical
expression, we examined the relation between the distinct
anatomic and angiographic features of CDAVF with LVD,
based on the “DES” (Directness and Exclusivity of
leptomeningeal venous drainage and features of venous
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Strain) scheme, and their clinical presentation. In parallel, we
examined the relation of the above features with the topogra-
phy of the lesions.Whether clinical presentation constitutes an
additional independent determining factor of poor natural
history [28] is an important related issue, addressed indirectly
in this study. A critical review of recent related publications is
also presented.
Materials and methods
From a series of 211 consecutive patients with CDAVF treated
in our department during the last 19 years, 107 patients
demonstrating a lesion with LVD had complete angiographic
images [2]. Among them, 36 patients had lesions with mixed
leptomeningeal and dural drainage (Borden [3] grade 2 and
Cognard [5] grades IIb, IIa + b) and 71 cases had lesions with
LVD only (Borden grade 3 and Cognard grades III, IV, V).
Cases of pediatric and/or congenital CDAVFs were excluded.
The angiographic images of all cases were analyzed by two
specialists blinded to the clinical presentation data. They
recorded data on the base of the DES (Directness, Exclusivity
of leptomeningeal venous drainage and venous Strain) con-
cept. A direct LVD is characterized by a venous drainage
through the bridging vein(s) (BV) to the leptomeningeal ve-
nous system without interposition of a sinus. Therefore, the
directness of the LVD is the expression of the exact location of
the shunt on a bridging vein. An exclusive LVD was defined
as venous drainage by only the leptomeningeal veins. There-
fore, the exclusivity of the LVD is mostly the expression of
venous outflow restrictions (VOR) as complete or partial sinus
thrombosis or stenosis. The characteristics of venous strain
included congestion with pseudophlebitic appearance [27, 16,
8] of the leptomeningeal veins as well as venous ectasia. In
our descriptions, ectasia and varix were deemed as synony-
mous terms and, together with venous aneurysms, were con-
sidered as signs of focal structural decompensation of the
cerebral venous system, likely linked to hemorrhagic presen-
tation. Uniformly dilated veins along their entire course, with-
out signs of ectasia or aneurysm, although they certainly
express some degree of venous hypertension, were not
deemed signs of venous decompensation, and therefore, were
not recorded as venous strain. The so-called pseudophlebitic
pattern of the venous systemwas considered as another sign of
venous decompensation with congestion and stagnation,
heralding venous infarction, and likely linked to progressive
neurological deficit. Interobserver agreement for the recorded
data was evaluated between the two readers and cases of
disagreement were settled by consensus.
In this way, the three main aspects D, E, S of the CDAVF
angioarchitecture were compared to the clinical presentation
of the lesions. Although hemorrhage (H) is usually recorded
together with other aggressive presentations, we opted to
record it also separately taking into account that hemorrhage
is always a sudden and irreversible event, very often with
significant impact on the brain. Progressive neurological def-
icit (PND) due to regional venous congestion or mass-effect of
a venous varix or dementia, which have a more gradual and
possibly reversible course were also recorded as aggressive
presentations. TIA and epilepsy, which are mostly episodic
and rather warning neurological manifestations (NM) were
not included in the aggressive presentation group because
from a purely clinical point of view, they were deemed as
intermediate clinical presentation. Therefore, the sum of hem-
orrhages and PND was referred to as aggressive presentation
(AP). Benign was defined as the clinical presentation when
symptoms including tinnitus, atypical headaches, and/or diz-
ziness and those related to orbital venous congestion, were
described. Cases that presented with cranial nerve deficits and
diplopia, facial nerve palsy, or glaucomawith decreased visual
acuity, were not included in the benign group [19, 9], because
from a purely clinical point of view, they were considered to
have an intermediate severity. These symptoms, together with
the NM, were defined as intermediate presentation (IP). An
incidental discovery was not considered a benign presentation
and was not counted in the calculation of percentages. In
patients with multiple lesions, only the higher-grade shunt
with LVD was considered.
Accordingly, the patients were grouped into the following
eight groups: the nD-nE-nS group with non-direct, non-
exclusive LVD, without cortical venous strain; the nD-nE-S
group with non-direct, non-exclusive LVD, with cortical ve-
nous strain; the nD-E-nS group with non-direct, exclusive
LVD, without cortical venous strain; the nD-E-S group with
non-direct, exclusive LVD, with cortical venous strain; the D-
nE-nS group with direct, non-exclusive LVD, without cortical
venous strain; the D-nE-S group with direct, non-exclusive
LVD, with cortical venous strain; the D-E-nS group with
direct and exclusive LVD, without cortical venous strain;
and the D-E-S group with direct and exclusive LVD, with
cortical venous strain.
We hypothesized that each group should show varying
degrees of aggressive clinical presentation. An exact condi-
tional chi-squared test for small samples was used to access
statistical significance of aggressive clinical presentation
among the groups by testing independence of group and AP
[13]. The effect of each angioarchitectural characteristic of the
DES system, namely directness (D), exclusivity (E), and
venous strain (S) on the clinical presentation, possible associ-
ation of venous strain pattern (pseudophlebitic congestion and
venous ectasia) with distinct aggressive clinical presentations
and association of anatomic locations with a specific type of
shunt were also investigated.
Interobserver agreement for each of the three
angioarchitectural main features (D, E, and S) was calculated
using Cohen kappa coefficient.
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Results
Patient data and group assignment are shown in Table 1.
All 50 patients with non-direct (nD) LVD carried by
definition a shunt based in the sinus, called “dural sinus
shunt” (DSS). Among them, the groups with exclusive
LVD correspond to the so-called isolated sinus shunt
(ISS). The rest of the 57 patients with direct (D) LVD
correspond to shunts based in BVs, thus called BV shunts
(BVS), with the vast majority having an exclusive LVD at
the time of presentation; only 4 (7 %) of these shunts had
a non-exclusive LVD.
Shunts with non-direct LVD None of the shunts of the nD-nE-
nS group had an aggressive presentation (0 %). From the nD-
nE-S group, three patients presented with bleeding (33 %);
two with venous hypertension-dementia, therefore, an overall
aggressive presentation in 55.5 %; one with epileptic attack,
whereas, three patients with tinnitus. Most of the nD-E-nS
group presented with benign symptoms. Two patients present-
ed with a small hemorrhage in the hemisphere contralateral to
the lesion; none had a draining vein near. One had a known
coagulopathy, which was considered the cause of bleeding
since the contralateral occurrence was difficult to be attributed
to the shunt; thus, it was deemed as an incidental finding. The
second patient had no other apparent cause for the bleeding
and it was deemed his clinical presentation. From the nD-E-S
group, two patients presented with bleeding (20 %), four
patients with progressive neurological deficit due to regional
venous congestion, one patient with dementia, two with epi-
lepsy, one with headaches, and one with small co-incidental
stroke of the pons; therefore, an aggressive presentation was
recorded in 70 % of cases.
Shunts with direct LVD One case fromD-nE-nS group was an
incidental finding, whereas the second case presented with
tinnitus and suspicion of epileptic attack. The D-nE-S group
also included two cases: one presenting with epilepsy and the
second with strong headaches and dizziness. Among the 16
cases of the D-E-nS group, 3 patients presented with bleeding
(23 %), 4 patients with progressive neurological deficit
(31 %), 1 with epilepsy, 2 with TIA, 3 with atypical symp-
toms, including headaches, balance disturbances, dizziness,
amaurosis, prominent frontal veins, leg tremor, and lip numb-
ness, which were considered manifestations of the benign
spectrum, plus 3 patients with their lesion incidentally discov-
ered. Therefore, the aggressive presentation rate of this group
was 54 %. Among the 37 patients of the D-E-S group, 27
presented with bleeding (75 %), 6 with progressive neurolog-
ical deficit (16.5 %), 1 with TIA, 1 with epilepsy, 1 with
atypical symptoms as headaches, dizziness, fall attacks with
and without loss of consciousness, and 1 patient with a lesion
incidentally discovered. Therefore, the aggressive presenta-
tion rate of this group reached the 91.5 %.
Overall, the distribution of AP differed significantly be-
tween the groups (p value<0.001). The presence of each
angioarchitectural feature (D, E, and S) significantly more
often led to AP as compared to lesions with absence of these
features (nD, nE, and nS) (Table 2).
A collective diagrammatic representation of the distribu-
tion of clinical presentations among the groups is presented in
Fig. 1.
Table 1 Group, number, demographics, and clinical presentation of patients according to the DES features
Group nD nD nD nD D D D D
nE nE E E nE nE E E
nS S nS S nS S nS S
Number 23 9 7 11 2 2 16 37
% 21.5 8.5 6.5 10 1.9 1.9 15 34.5
Male (%) 11 (48) 6 (66) 4 (66) 9 (75) 1 (50) 1 (50) 9 (60) 30 (79)
Age mean 55 51 57 58 64 69 58 56
Incidental 0 0 1a 1 1 0 3 1
H 0 % 3 (33 %) 1 (16.5 %)b 2 (20 %) 0 (0 %) 0 (0 %) 3 (23 %) 27 (75 %)
PND 0 % 2 (22.5 %) 0 (0 %) 5 (50 %) 0 (0 %) 0 (0 %) 4 (31 %) 6 (16.5 %)
NM 0 % 1 (11 %) 0 (0 %) 2 (20 %) –c 1 (50 %) 3 (23 %) 2 (5.5 %)
CND 27 % 0 (0 %) 2 (33 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %) 0 (0 %)
AP 0% 5 (55.5%) 1 (16.5%) 7 (70%) 0 (0%) 0 (0%) 7 (54%) 33 (91.5%)
Incidental incidentally discovered lesions, H hemorrhage, PND progressive neurological deficit, NM neurological manifestation, CND cranial nerve
deficit, AP aggressive presentation
a Patient with bleeding in the hemisphere contralateral to the lesion and known coagulopathy
b Patient with contralateral bleeding not possible to be attributed to another pathology
cOne patient presented with benign symptoms and doubtable epileptic attack. In the other patient, it was incidentally discovered
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The ISSs (nD-E-nS + nD-E-S) in comparison to BVSs (D-
E-nS + D-E-S), both with exclusive LVD, had significantly
less aggressive presentation, overall 50 vs. 81.5 % (p value
0.007). The ISS with venous strain (group nD-E-S) in com-
parison with the corresponding BVS with venous strain
(group D-E-S), despite that they both showed a high rate of
overall aggressive presentation, the hemorrhages, were signif-
icantly lower in the sinus-based shunts, 20 vs. 75 % (p value
0.002).
Among the “S” groups (with venous strain), the presence
of ectasia was significantly associated with hemorrhage (p
value <0.001) whereas the presence of congestion was signif-
icantly associated with PND (p value 0.04) (Table 3).
Among the four dural sinus shunt groups (all the nD ones)
the transverse and/or sigmoid sinuses were the most common
locations (76 %), with the cavernous sinus being the second
most common site (Table 4). As seen in Table 5, the tentorial
BVs together with petrosal BVs were, by far, the most
Table 2 Effect of D (directness of LVD), E (exclusivity of LVD), and S
(venous strain) on the clinical presentation of CDAVFs
D/nD p value E/nE p value S/nS p value
Case no. 52/48 65/35 57/43
AP 40/13 0.0001 48/5 0.0001 45/8 0.0001
AP* 46/16 0.0001 55/7 0.0001 51/11 0.0001
AP aggressive presentation,H hemorrhage, AP* aggressive presentations
according to previous definition [9]
Fig. 1 Diagrammatic representation of the distribution of clinical pre-
sentations among the groups, displayed according to the AP risk, from
lowest (left) to highest (right). Their angioarchitecture, described in DES
terms, appears at the bottom of the columns. At the top of the columns, the
alternative description (DSS, ISS, BVS) is shown. The dural sinus shunt
(DSS) groups correspond to the Borden type 2 lesions, the ISS groups
correspond to the isolated sinus shunts variety of DSS (Borden type 3),
and the BVS groups, to the bridging vein shunts (Borden type 3). The D-
nE-nS and D-nE-S groups are not shown due to rarity. The benign
presentations appear in green color. The gray colors symbolize an inter-
mediate clinical presentation. The light gray color under the name
“CND” represents the cases presenting with cranial nerve deficits. The
dark gray color represents the cases presented with episodic neurological
manifestations (NM). The dark red “aggressive-H” presentation stands
for hemorrhage, whereas the red “aggressive-PND” for progressive neu-
rological deficit. This chart summarizes the main results of the study.
Overall, on the left side, the three groups with lower AP have no venous
strain (nS), whereas the three groups on the right side have venous strain
(S). The sequence of types according to AP remains the same on both
sides: DSS, ISS, BVS. Sinus-based shunts (DSS) with non-exclusive
LVD and without venous strain had 0 % AP. On the other end of the
spectrum, the bridging vein shunts (BVS) with venous strain were the
most aggressive with 91.5 % AP. In the middle, the bridging vein shunts
without venous strain and the sinus shunts with venous strain, have a
moderate frequency of AP (54 and 55.5 %, respectively). The ISSs and
BVSs with venous strain differ significantly in the percentage of hemor-
rhage (20 vs. 75 %, respectively)
Table 3 Relation between venous strain pattern and specific presentation
Groups Congestion Ectasia Both
nD-nE-S 2 Bleedingsa 1 Bleeding 0 Bleeding
2 PND 0 PND 0 PND
1 NM 0 NM 0 NM
1 Benign 1 Benign 1 Benign
nD-E-S 1 Bleeding 1 Bleeding 0 Bleeding
4 PND 0 PND 1 PND
0 NM 0 NM 2 NM
1 Benign 0 Benign 0 Benign
1 Incidental
D-nE-S 1 NM 1 Benign
D-E-S 3 Bleedings 24 Bleeding 0 Bleeding
1 PND 5 PND 0 PND
0 NM 0 NM 2 NM
0 Benign 1 Benign 0 Benign
1 Incidental
PND progressive neurological deficit, NM neurological manifestation,
Both congestion and ectasia
aOne patient with coexisting multiple cavernomas and the second patient
with evidently high-flow shunt
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frequent locations of the BV shunts. In addition, tentorial
shunts, being BV-based shunts, all had a direct and nearly
all-exclusive CVD. All ethmoidal shunts had also a direct and
exclusive CVD.
The four ethmoidal dural shunts of the D-E-S group
showed an overall aggressive presentation 50 % (both bleed-
ings) and one NM. From the five ethmoidal cases of the D-E-
nS group, none presented with bleeding, one was incidentally
discovered, three presented with benign symptoms, and one
with epilepsy. The rate of aggressive presentation of the
ethmoidal dural shunts was markedly lower in comparison
to the general rate of the corresponding groups, namely 0 vs.
54% (p value 0.12) and 50 vs. 91.5% (p value 0.09) for the nS
and S varieties, respectively. The distribution of the two
subtypes of anterior cranial fossa shunts (ethmoidal BV shunts
and cribrosal shunts) among the S and nS groups and their
presentation were not studied, since their small numbers did
not allow further analysis.
There was no significant difference between sex distribu-
tion comparing sinus vs. BV lesions (72 % with BVS and
60 % with DSS were men; p value 0.28).
The interobserver agreements on the three main
angioarchitectural features were per definition perfect for di-
rectness and exclusivity, with Cohen kappa coefficients 0.96
and 0.91, respectively, and substantial for venous strain pat-
terns, with kappa coefficient of 0.69.
Discussion
In many CDAVF studies, hemorrhages, focal or global neu-
rological deficit, and neurological manifestations including
TIA and epilepsy, are deemed as an aggressive presentation,
whereas cranial nerve palsy and visual impairment due to
glaucoma are grouped together with headache, tinnitus, and
orbital phenomena in the benign spectrum of symptoms [19,
26, 9]. This consideration about the benign or aggressive
nature of symptoms is mostly based on the relation of the
symptoms to the central (CNS) vs. peripheral nervous system
(PNS), which certainly has a value. However, from a purely
clinical point of view (as we are dealing with clinical presen-
tation), we should notice that an epileptic attack in terms of
severity and impact is very dissimilar from an intracerebral
bleeding, although both are related to the CNS. On the other
hand, the clinical impact of diplopia and glaucoma with
impaired vision is certainly different than the impact of tinni-
tus, with the former always receiving urgent medical attention.
Hence, we decided to abandon the dipole benign-aggressive,
evocative of a black-white approach and consider epileptic
attacks and TIAs as episodic neurological manifestations hav-
ing an intermediate severity and mostly representing warning
features. We found this standpoint more close to a balanced
and realistic clinical approach. We also think that categorizing
cranial nerve deficits as benign symptoms, although widely
accepted, cannot be really justified. These symptoms, al-
though related to the PNS, should rather be grouped in a gray
zonewith the intermediate symptoms from the central nervous
system rather than in the benign spectrum, due to their dis-
abling nature. A view of the clinical presentation distribution
among the groups based on the above consideration appears in
Fig. 1. Additionally and contrary to previous studies [9, 25],
we did not count incidental discovery in the benign presenta-
tion because we deemed that it does not amount to presenta-
tion; we considered that incidental discovery happens before
the lesion develops symptoms, which can be either aggressive
or benign, regardless.
Our results demonstrated that among CDAVFs with LVD,
there are significant angioarchitectural differences, which are
reflected by considerable differences in clinical presentation.
LVD of sinus-based shunts that is neither direct nor exclusive
Table 4 The nD (sinus-based shunt) groups and their location
Location Groups
nD-nE-nS nD-nE-S nD-E-nS nD-E-S
Cavernous sinus 5 0 2 0
Transverse and/or
sigmoid sinus
13 8 5 9
Transverse and
occipital sinus




1 0 0 2
Sphenoid wing 1 1 0 0
Jugular bulb 2 0 0 0
Table 5 Locations of lesions of the D groups (with direct LVD). All of
them are BV shunts, with the cribrosal subtype of the ethmoidal shunts
presenting a rather bridging-emissary vein configuration
Location Groups
D-nE-nS D-nE-S D-E-nS D-E-S
Superior convexial BV 0 1 2 3
Tentorial BV 1 0 0 12
Petrosal BV 0 1 7 7
Pontine BV 0 0 1 0
Medullary BV 0 0 1 4
Galen BV 0 0 0 2
Transverse sinus BV 0 0 0 3
Temporal BV 1 0 0 0
Sphenoid wing BV 0 0 0 2
Ethmoidal 0 0 5 4
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and without venous strain is not expected to present aggres-
sive symptoms. On the other end of the spectrum, the BV-
based shunts with direct and exclusive LVD and venous strain
will present aggressively almost always and most likely with
bleeding.
The most aggressive of the sinus shunts, those with exclu-
sive LVD and venous strain (corresponding to an ISS with
cortical venous strain), despite the fact that they showed a high
rate of overall aggressive presentation, the hemorrhage rate, in
comparison to a BV shunt with cortical venous strain, was
significantly lower. This shows that the most aggressive BVSs
present more frequently with hemorrhage, whereas the most
aggressive DSSs present more frequently with PND.
Another interesting point to mention was the fact that
nearly all BVSs had an exclusive LVD at the time of diagno-
sis. Only four patients had non-exclusive LVD, and none of
them presented with bleeding. The first case was discovered
incidentally; the flow to the transverse sinus was distinguish-
able only during a superselective injection, which speaks for a
rather low flow. The second lesion, similar to the first, was a
temporal BV shunt with some residual drainage to the trans-
verse sinus, presented with tinnitus (and suspicion of focal
epileptic attack). The third case was a shunt of a superior
convexial parietal BV. Although the exit of the BV to the
sinus was still patent, there was a medullary venous reflux due
to lack of superficial collaterals of that particular vein. This
explains why the patient presented with epilepsy, while flow
still existed to the sinus at the time of presentation. The fourth
case was a shunt of the superior petrosal vein with its exit to
the superior petrosal sinus and cavernous sinus not completely
occluded. Despite the ectatic changes of the draining vein, the
presentation was still benign with headache and dizziness.
Most likely, when the BV-exit to the sinus is still available,
the existing leptomeningeal venous hypertension is far
from its zenith, which matches for the incidental discovery
of the first and the still benign presentation of the second
and fourth cases. The D-nE shunts (S and nS included)
could be considered a transitional phase in the development
of BVSs, presumably towards exclusive and aggressively
symptomatic LVD. Accordingly, the small number of these
groups (D-nE-nS and D-nE-S) should not be considered a
particularity of our series or weakness of the DES concept.
On the contrary, it should be deemed as a merit of the
concept since it captures a relatively silent phase of other-
wise aggressive shunts, reflecting thus the dynamic nature
of these lesions.
The distribution of intermediate presentation (IP) among
the groups showed that (1) BVSs did not present with cranial
nerve deficits. The fact that these symptoms were recorded
only in patients with DSS without venous strain seems pri-
marily location-specific (all CS shunts belonged to the nD-nE-
nS and nD-E-nS groups) and not grade-specific. (2) Among
the nS shunts, only the BVSs presented with NM and indeed
in a remarkable proportion of 23 %. In other words, BVSs
even without venous strain showed a high rate (77 %) of non-
benign (AP + IP) presentation. (3) The ISSs with venous strain
can manifest themselves with warning symptoms (IP 20 %).
(4) The BVSs with venous strain rarely showed warning
symptoms (IP only 5.5 %).
All cases with non-exclusive LVD correspond to Borden
type 2 lesions and the cases with exclusive LVD belong to
Borden type 3. If we exclude the ISS from the Cognard types
III and IV, then our D-E-nS group corresponds to the Cognard
type III and the D-E-S group with the type IV. We see that
within the Borden type 2 lesions, as a consequence of signif-
icant differences in angioarchitecture, there are considerably
divergent clinical expressions; both nD-nE-nS and nD-nE-S
groups belong to the Borden type 2 with 0 and 55.5 %
aggressive presentation, respectively. Therefore, the fact that
some lesions with LVD have a benign presentation, in contrast
to other lesions with LVD, is absolutely tenable since LVD
alone does not appear to be the determining factor of the
clinical presentation. Directness and exclusivity of the LVD
and their impact on the venous system, expressed by concrete
signs of failure (ectasia and/or congestion) seem to play the
protagonist roles. The cause of this failure may be primarily
dependent on the collateralization [7] of the affected individ-
ual venous system as other authors have hypothesized [26, 25,
4, 23]. Additionally, the factor of time should be always
considered in both directions [15]. Other factors and comor-
bidities such as coagulopathies should also be considered as
relevant in some cases [21]. The causative relation of the
bleeding contralateral to the lesion in one patient of the nD-
E-nS group remains unclear although it was included in the
analysis. The other patient of the same group was considered
as an incidental discovery since the bleeding at presentation
could be better attributed to the underlined coagulopathy.
In the literature, it is often mentioned that the mode of
presentation is intrinsically linked to the shunt topography;
with classic examples, the anterior cranial fossa and tentorium,
both locations linked to an aggressive presentation [1, 19, 20,
12, 14, 22, 28]. Our study shows that topography, being
intrinsically linked to a specific venous anatomy, determines
the angioarchitectural features of the dural shunts, which
ultimately dictate the clinical presentation (Tables 4 and 5).
The groups without venous strain (nS) showed the lowest
AP rate in comparison with the groups with venous strain (S).
Among the three nS and three S groups, the DSSs showed the
lowest AP rates and the BVSs the highest AP rates (see
Fig. 1). It seems that venous strain is a strong determinant of
an aggressive clinical behavior, reasonably enough, since
venous strain signifies the disarrangement of the venous sys-
tem. This disarrangement can be focal and structural,
expressed by ectatic lesions, or more regional and functional,
expressed by venous congestion and stagnation. The impor-
tance of venous ectasia and its correlation with risk of
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bleeding has been previously demonstrated [4, 5]. Bulters
et al. have actually expressed their thoughts about a potential
simple classification of CDAVFs based only on the presence
of venous ectasia. Our results advocate a way of analysis and
concretely, the DES concept, which takes venous strain very
seriously into consideration but not as the only criterion and
the ectasia not as the only expression of venous strain. Ac-
cording to our study, the directness of the LVD correlates with
the ectatic version of the venous strain, which is linked to
hemorrhagic presentation; which makes absolute sense. On
the other hand, a non-direct shunt, as in the case of ISS,
appears more related to the congestive, regional version of
venous strain, which is linked mostly with non-hemorrhagic
neurological deficits; which also makes sense because a shunt
of an isolated sinus segment empties indirectly and often into
more than one BV.
Interestingly, the rate of aggressive presentation of the
ethmoidal dural shunts, although by definition they belong
to the D-E groups, was considerably lower in comparison to
the general rate of the groups, for the nS and S varieties,
respectively. We found no apparent reason explaining this.
The peculiar venous anatomy with spinal cord-like bridging-
emissary vein [17] configuration and bidirectional flow in the
area of the lamina cribriformis may play a role. Also, the
ethmoidal BVS subtype of this group may show a tendency
for aggressive presentation in comparison to the cribrosal
subtype of the same group, but the numbers were too small
for further analysis.
Recently, Shin et al. [23] analyzed the angioarchitectural
venous features of a series of 41 CDAVFs and found that ISS
had an aggressive presentation in all cases (100 %) and a
hemorrhagic presentation in 20 % of cases, although they
did not correlate these percentages with presence or absence
of ectasias and congestion in the above cases. Their results are
in accordance with ours regarding the hemorrhagic presenta-
tion (ours 23.5 %), but contradict with our overall aggressive
presentation of 65 % for both ISS groups. For the lesions with
direct CVD, they found an overall aggressive presentation
similar to ours (89 vs. 92 % if we sum our aggressive presen-
tations with NM, as they did) but significantly lower hemor-
rhagic presentation, i.e., 33 vs. 61 % (the average for our two
groups with direct LVD). These discrepancies may reflect
population bias or differences in angiographic analysis of the
cases. They also found that “brisk drainage” reported in 14/41
cases, was correlated with benign presentation, in contrary to
the pseudophlebitic appearance of the draining veins reported
in 30/41, which was correlated with aggressive presentation.
The above implies that three patients had both brisk drainage
and pseudophlebitic draining veins, which was not specifical-
ly analyzed. Regarding the involvement of a long network of
cortical veins in the drainage of a CDAVF, they concurred
with previous observations [10] that patients with aggressive
presentation were significantly associated with a longer length
of LVD. An exact definition of “length” and reliable way of
measurement were not provided. Although similar data were
not collected in the current study, the above observation can be
warranted since it reflects the collateralization capacity of the
regional venous system and more concretely, the availability
of a short-course collateral venous exit to the nearest sinus.
The assumption that different clinical presentations of
CDAVFs with LVD may signify a different clinical course
was based on the observation that some CDAVFs with LVD
had an aggressive presentation and others, not [25, 24]. A
reasonable question is whether this observation is well sup-
ported and if, in fact, the shunts with aggressive presentation
are the same lesions with those presenting with a benign
mode. As our results showed and other authors noted, LVD
as the only criterion for prediction of clinical presentation is
not enough [25], since, e.g., nD-nE-nS lesions in comparison
with D-E-S lesions have a huge difference in terms of archi-
tecture and clinical presentation.
Strom et al. [25] reported that CDAVFs with LVD present-
ed with benign symptoms or incidentally, may have a less
aggressive clinical course than those that presented with
bleeding and neurological deficit. However, their study had
some weaknesses. Their conclusions were based on 17 cases
of the benign presentation group and 11 cases of the aggres-
sive presentation group. Regarding the former group, a meth-
odological weakness was the inclusion of seven incidentally
discovered lesions (41 %), despite the fact that one of the
incidentally discovered shunts presented later with bleeding,
after refusing treatment. Six of these seven incidental lesions
were Borden type 3; in total, eight lesions were Borden type 3.
No data about ISS were provided. The above would mean that
6/8 shunts (75 %), which had the higher potential of an
aggressive presentation, at the time of diagnosis had not
expressed it yet since they were discovered incidentally.
Looking at the locations of Borden type 3 lesions, three shunts
(“transverse,” “sigmoid,” “torcular”) appeared to be likely
sinus-based lesions (ISS), twowere likely BV shunts (“clivus”
and “petrous”) whereas the location of three shunts was non-
specifically recorded (“occipital area,” “frontal region,” and
“cranial base”). If we accept the above assumption correlating
the described location with the nature of the lesion (sinus vs.
BV shunt), then the BV shunts, which have a direct and
mostly exclusive LVD and are expected to have a more
aggressive presentation than a sinus shunt, counted only up
to 25 % of the Borden 3 lesions and 12 % of the entire group
of benign presentation. Moreover, only 1 shunt of the 17 had
signs of venous strain and was described as Cognard type IV.
Venous strain phenomena were recorded for none of the nine
Borden type 2 lesions, unknown if because none of the used
classifications anticipate such phenomena for type 2 lesions or
because none had one. According to our findings, lesions
without venous strain are expected to have relatively benign
presentation. Such lesions may be expected to continue
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having a benign clinical behavior as long as their architecture,
which mostly determines their presentation, does not change.
In the same report by Strom et al., the group of aggressive
presentation comprised five Borden type 2 shunts and six
Borden type 3 shunts, of those one Cognard type IV and one
type V. Looking at the locations of the Borden type 3 lesions,
four shunts (two “tentorium”, two petrous) appear most likely
as BV lesions and two (transverse) likely as ISS. Again, if we
accept the above assumption correlating the described loca-
tion with the nature of the lesion as presumably true, then the
BV lesions, with the higher potential to present aggressively,
made up 66.5 % of the Borden 3 lesions (vs. 25 % of the
benign presentation group) and 36 % of the entire group of
aggressive presentation (vs. 12 % of the benign presentation
group). Therefore, the inhomogeneity of the groups, defined
only on the base of presence of LVD, and the above-presumed
difference in the percentage of BV shunts between the benign
and aggressive presentation group, might be the reason for this
distinct clinical expression. Apart from the above-analyzed
weaknesses, Strom et al. did note that LVD might not be a
reliable indicator of cortical venous hypertension, an observa-
tion supported by our study. Further, they suggested that less
flow through the fistula, more efficient collateral pathways, or
other factors at a microvascular level, may explain why le-
sions with LVD have a non- or less aggressive presentation,
but failed to refer to the heterogeneity of the “LVD group”
itself as a confounding factor.
Söderman et al. [24], in their study on natural history of
dural shunts, similarly, analyzed their population by mixing
together lesions with exclusive and non-exclusive LVD. Of
the eight Borden type 2 shunts presented with hemorrhage, no
data were provided about venous ectasia or pseudophlebitic
venous congestion. Of the 29 Borden type 3 shunts having a
non-hemorrhagic presentation, no data were provided about
number of lesions belonging to the ISS group.
The clinical presentation, as an additional criterion of a
classification system [28], linked to treatment recommenda-
tions, implies that presentation should be considered a deter-
mining factor of the clinical course, independent from the
anatomic background of the lesion. We consider clinical pre-
sentation as inherently linked to the anatomic background [19,
18]. If we contemplate a cause-effect scheme for the analysis
and prediction of behavior of these lesions, and we accept that
anatomy and angiographic features of a shunt belong to the
cause-side and the clinical presentation and course to the
effect-side, then the above attempt [28] is equivalent to a
partial displacement of the effect- into the cause-side, just to
make our predictions about future effect more successful
instead of analyzing the cause-side further. Moreover, the
predictive value of such an analysis and classification for
incidentally discovered lesions would be, by definition, void.
Furthermore, if we accept that incidental discovery should be
counted as benign presentation, then a classification taking
into account a thus defined clinical presentation, would be
misleading. Our study shows that angioarchitectural features,
previously ignored as distinct factors, can further explain the
different clinical expressions within the largely inhomoge-
neous group of lesions with LVD. Failure to identify these
factors in angiographic analyses and to recognize them as
determinants of the clinical presentation and (most likely)
course, may in fact make the use of the clinical presentation
criterion “necessary” although conceptually inconsequent.
The substantial (but non-perfect) interobserver agreement
concerning the description of venous strain features reflects
the relative subjectivity in the comprehension and application
of defined criteria in complex cases. The analysis of data by
two readers aimed to diminish this limitation. We consider the
factor of angiographic analysis of images as the major limita-
tion of the current, as well as every study of this kind.
Conclusions
CDAVFs with LVD constitute a wide and inhomogeneous
group of lesions with significant angioarchitectural differ-
ences reflected by considerable differences in clinical presen-
tation. Instead of trying to elaborate the clinical course of
CDAVFs by considering their initial clinical expression,
which is rather a tautology, the DES scheme allows a more
concrete analysis of their angioanatomic features based on the
factors of directness and exclusivity of LVD in combination
with signs of significant cortical venous strain. This way of
analysis, in contrary to the currently used classifications,
enables the recording of differences among the subgroups
and may sufficiently provide the necessary criteria for predic-
tion of the clinical presentation and course of these lesions,
and furthermore the indications for treatment.
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Comments
Michihiro Tanaka, Kamogawa City, Japan
Directness and exclusivity of leptomeningeal venous drainage and
signs of venous strain were well described in corresponding to each
angiographic feature in terms of clinical manifestation of CDAVFs. The
discussion of clinical appearance and the existing of parenchymal venous
congestion or incidence of intracerebral hemorrhage is well appreciated.
Tentorial and petrosal BVs, as well as ethmoidal location, are highly
associated with the category of D-E-S. These locations are characterized
as the lateral epidural space group in the classification of Geibprasert, and
the malignancy of this group has been already discussed.
Karel terBrugge, Toronto, Canada
Dr. Baltsavias and the Zurich team are to be complemented on the in-
depth analysis of their extensive experience with DAVS and using it to
modify to interpret more accurately the to-be-expected risks of those
DAVS that are associated with so called “cortical venous reflux.” In their
analysis, it became clear that additional factors influenced expected
clinical risk and they included the presence of direct (D) and exclusive
(E) retrograde leptomeningeal reflux (LVR) as well as evidence of venous
strain (S). By analyzing each of the factors individually and in combina-
tion, it became clear that further stratification of the clinical risks in the
natural history of DAVS with LVR could be accomplished. This, in turn,
should be helpful to understand and manage patients with DAVS with
LVR including those that are incidentally discovered.
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